
Leash Bio builds large, high-quality data and models to advance drug discovery. They generate physical measurements through in-house automated protein production and screen targets against compounds using DNA-encoded libraries, while developing ML models that generalize across proteins and novel medicines. Core tech includes a foundation model for biology and chemistry, experimental datasets, and scalable ML workflows that leverage the measured data. Primary customers are pharma and biotech companies and research institutions seeking data-driven discovery. The company aims to scale biology and chemistry insights across targets and compounds to accelerate early-stage drug development.

Leash Bio builds large, high-quality data and models to advance drug discovery. They generate physical measurements through in-house automated protein production and screen targets against compounds using DNA-encoded libraries, while developing ML models that generalize across proteins and novel medicines. Core tech includes a foundation model for biology and chemistry, experimental datasets, and scalable ML workflows that leverage the measured data. Primary customers are pharma and biotech companies and research institutions seeking data-driven discovery. The company aims to scale biology and chemistry insights across targets and compounds to accelerate early-stage drug development.